Publication
Article Metrics
Citations
Online attention
Modest amyloid deposition is associated with iron dysregulation, microglial activation and oxidative stress
DOI:
10.3233/JAD-2011-110614
PMID:
21971404
Authors:
Joseph
Gallagher
(California Institute of Technology)
,
Mary
Finnegan
(University of Warwick)
,
Belinda
Grehan
(Trinity College Dublin)
,
Jon
Dobson
(Keele University)
,
Joanna
Collingwood
(University of Warwick)
,
Mariana
Lynch
(Trinity College Dublin)
Co-authored by industrial partner:
No
Type:
Journal Paper
Journal:
Journal of Alzheimer's Disease
State:
Published (Approved)
Published:
October 2011
Diamond Proposal Number(s):
1125
Abstract: There is a well-established literature indicating a relationship between iron in brain tissue and Alzheimer's disease (AD). More recently, it has become clear that AD is associated with neuroinflammatory and oxidative changes which probably result from microglial activation. In this study, we investigated the correlative changes in microglial activation, oxidative stress, and iron dysregulation in a mouse model of AD which exhibits early-stage amyloid deposition. Microfocus X-ray absorption spectroscopy analysis of intact brain tissue sections prepared from A?PP/PS1 transgenic mice revealed the presence of magnetite, a mixed-valence iron oxide, and local elevations in iron levels in tissue associated with amyloid-?-containing plaques. The evidence indicates that the expression of markers of microglial activation, CD11b and CD68, and astrocytic activation, GFAP, were increased, and were histochemically determined to be adjacent to amyloid-?-containing plaques. These findings support the contention that, in addition to glial activation and oxidative stress, iron dysregulation is an early event in AD pathology.
Journal Keywords: Iron; Alzheimer's Disease; Oxidative Stress
Subject Areas:
Medicine,
Biology and Bio-materials,
Technique Development
Instruments:
I18-Microfocus Spectroscopy
Discipline Tags:
Technical Tags: